Skip to content

Effect of Muktashukti Bhasma and Saubhagyashunti on the bone health of Nursing Mother Health consuming Traditional Diet food in Maharashtra.

Impact of Mukta Shukti Bhasma and Saubhagya Shunti in reversal of bone mineral density among lactating women consuming traditional diet foods in Maharashtra: A randomized controlled preliminary clinical study. - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067814
Enrollment
120
Registered
2024-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Central Council for Research In Ayurvedic Sciences, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married, apparently healthy, currently lactating mothers 21 - 40 years of age 2. Willing to continue exclusive breastfeeding their infant for at least 6 months post-delivery and partially breastfeed later on throughout the study period 3. The infant is less than 30 days at screening 4. Mother and infant are in good health, as determined by the study investigator 5. Willing to prevent conception (by use of a contraceptive) till the study period 6. Willing and able to participate in all aspects of the study including allocation of any of the study drugs – Mukta Shukti Bhasma and Saubhagya Shunthi or calcium citrate & Vitamin D supplements, follow-up visits and the procedures thereof, study retention period (12 months since recruitment), 7. Willing to provide informed written consent

Exclusion criteria

Exclusion criteria: 1. Currently on medication that affects Vitamin D metabolism like Steroids, anticonvulsants, or barbiturates etc. 2. Nursing Mutiple twins or have had any complication during the latest parturition or have had bad obstetric history 3. Taking greater than the daily recommended intake of 1000 mg elemental calcium as calcium supplements 4. Mother with baseline 25(OH)D levels greater than 70ng/ml 5. Women using contraceptives like medroxyprogesterone acetate, oral contraceptives 6. Infant weight below 2kg at the time of recruitment in the study 7. Advised or willing to undergo any major surgery during the study period 8. History of Hypo/Hyperthyroidism, Diabetes mellitus 9. History of urolithiasis or any other disease condition (like cardiovascular, pulmonary disease, rheumatoid arthritis or any other auto-immune or chronic inflammatory disease) or known hypersensitivity to any of the trial drugs or their ingredients that may jeopardize the study 10. Not residing in the locality accessible for the research staff for follow up visits

Design outcomes

Primary

MeasureTime frame
1. Clinical Efficacy: Comparison of change and time trend analysis in the BMD at lumbar spine (L1 to L4), Dual Femur (neck and total ) and left Radius (33% and ultra-distal) among the Mukta Shukti Bhasma with Saubhagya Shunthi Vs Calcium citrate with vitamin D supplemented groups of women. 2. Comparison of the effect of the trial drugs on Bone Metabolism parameters (ionic calcium, phosphorus, magnesium, 25 hydroxy vitamin D, intact parathormone, Bone specific alkaline phosphatase, CTX, P1NP) in lactating women Timepoint: 1. Baseline, 6 months and 12 months 2.1. Bone-specific alkaline phosphatase, CTX, P1NP - Baseline, 3 months, 6 months and 12 months 2.2. ionic calcium, phosphorus, magnesium, 25 hydroxy vitamin D, intact parathormone - Baseline and 12 months

Secondary

MeasureTime frame
1. Incidence of Treatment emergent adverse events in both groups 2. Drug compliance achieved in both groups 3. Time trend analysis of the association of dietary macronutrients on the body composition parameters like Visceral Adiposity Tissue, android fat mass, gynoid fat mass, anthropometric measurements among the participants in both groups 4. Improvement in Quality of Life as assessed by MAPP-QOL among the participants in both groups. Timepoint: For 1, 2 and 4 - Baseline, 3 months, 6 months, 9 months and 12 months For 3 - Baseline, 6 months and 12 months

Countries

India

Contacts

Public ContactDr R Govind Reddy

CCRAS RRAP Central Ayurevda Research Institute Mumbai

drrgreddy68@gmail.com9820284671

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026